Acura Pharma (ACUR) Misses Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts ACUR Hot Sheet
Price: $0.00 --0%
Financial Fact:
Total operating expenses: 2.29M
Today's EPS Names:
RCBC, GASS, YSG, More
Financial Fact:
Total operating expenses: 2.29M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Acura Pharma (NASDAQ: ACUR) reported Q3 EPS of ($0.08), $0.05 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $2.68 million versus the consensus estimate of $2.7 million.
For earnings history and earnings-related data on Acura Pharma (ACUR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- Dell Technologies (DELL) Tops Q2 EPS by $2.17, Offers Guidance
- Goldman Sachs Downgrades Societe Generale SA (GLE:FP) (SCGLY) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
